Close Menu

NEW YORK (GenomeWeb) – Qiagen said today that its Artus T. vaginalis QS-RGQ kit has received CE marking and is now commercially available in Europe.

The real-time PCR assay is designed for the qualitative detection of Trichomonas vaginalis DNA purified from clinician-collected vaginal swabs, endocervical swabs, and urine samples from symptomatic and asymptomatic patients.

The test is configured for use with the QiaSymphony RGQ system, which comprises the QiaSymphony SP/AS (sample prep/assay setup) and Rotor-Gene Q instruments.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.

Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.

St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.

In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.

Apr
30
Sponsored by
Lexogen

This webinar will discuss novel long-read transcript sequencing (LRTseq) methods for transcriptome annotation that could increase the efficiency and accuracy of future sequencing projects.

May
01
Sponsored by
Illumina

This webinar will discuss the benefits of virus-specific target capture combined with next-generation sequencing (NGS) to identify viral infections and conduct comprehensive genomic and transcriptomic interrogation.